Guardant Health (GH) EBIT Margin Growth (3y) (2020 - 2026)
Guardant Health (GH) EBIT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -168.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 360.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -247.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,378.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 146.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 20.00 |
| 10 | Guardant Health | 21.59 Bn | 20.53 Bn | 219.03 Mn | 4,867.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,867.00 |
| Mar 31, 2026 | 6,392.00 |
| Dec 31, 2025 | 7,220.00 |
| Sep 30, 2025 | 8,584.00 |
| Jun 30, 2025 | 7,355.00 |
| Mar 31, 2025 | 7,377.00 |
| Dec 31, 2024 | 2,843.00 |
| Sep 30, 2024 | 5,192.00 |
| Jun 30, 2024 | 4,925.00 |
| Mar 31, 2024 | 7,795.00 |
| Dec 31, 2023 | -1,097.00 |
| Sep 30, 2023 | 2,019.00 |
| Jun 30, 2023 | -488.00 |
| Mar 31, 2023 | -5,244.00 |
| Dec 31, 2022 | -7,388.00 |
| Sep 30, 2022 | -9,444.00 |
| Jun 30, 2022 | -9,112.00 |
| Mar 31, 2022 | -6,379.00 |
| Dec 31, 2021 | -753.00 |
| Sep 30, 2021 | -161.00 |